newsfilter
← Latest News
ACCESS Newswire·

Dogwood Therapeutics Files New Synthetic Halneuron(R) Intellectual Property Protection Projected to Extend Exclusivity Period Up to 2045

- New Composition of Matter Intellectual Property Filing Centered on First-in-Class, Fully Synthetically Manufactured Halneuron®-- New Synthetic Process to be Used for Phase 3 Development Provides